- Home
- ITGR vs SBRA Comparison
ITGR vs SBRA Comparison
Compare ITGR & SBRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITGR
- SBRA
- Stock Information
- Founded
- ITGR 1970
- SBRA 2010
- Country
- ITGR United States
- SBRA United States
- Employees
- ITGR N/A
- SBRA N/A
- Industry
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SBRA Real Estate Investment Trusts
- Sector
- ITGR Health Care
- SBRA Real Estate
- Exchange
- ITGR Nasdaq
- SBRA Nasdaq
- Market Cap
- ITGR 4.2B
- SBRA N/A
- IPO Year
- ITGR 2000
- SBRA N/A
- Fundamental
- Price
- ITGR $117.46
- SBRA $18.41
- Analyst Decision
- ITGR Strong Buy
- SBRA Buy
- Analyst Count
- ITGR 10
- SBRA 7
- Target Price
- ITGR $145.90
- SBRA $19.71
- AVG Volume (30 Days)
- ITGR 417.4K
- SBRA 2.5M
- Earning Date
- ITGR 07-24-2025
- SBRA 08-06-2025
- Dividend Yield
- ITGR N/A
- SBRA 6.51%
- EPS Growth
- ITGR N/A
- SBRA 185.79
- EPS
- ITGR 2.18
- SBRA 0.60
- Revenue
- ITGR $1,746,192,000.00
- SBRA $720,247,000.00
- Revenue This Year
- ITGR $11.03
- SBRA $6.34
- Revenue Next Year
- ITGR $7.29
- SBRA $7.13
- P/E Ratio
- ITGR $54.21
- SBRA $30.77
- Revenue Growth
- ITGR 10.19
- SBRA 10.76
- 52 Week Low
- ITGR $104.93
- SBRA $15.60
- 52 Week High
- ITGR $146.36
- SBRA $20.03
- Technical
- Relative Strength Index (RSI)
- ITGR 42.39
- SBRA 52.67
- Support Level
- ITGR $116.25
- SBRA $18.27
- Resistance Level
- ITGR $122.99
- SBRA $18.99
- Average True Range (ATR)
- ITGR 2.41
- SBRA 0.35
- MACD
- ITGR -0.24
- SBRA -0.02
- Stochastic Oscillator
- ITGR 16.07
- SBRA 34.83
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.